United Therapeutics Corporation Free Cash Flow Generation Index
United Therapeutics Corporation free cash flow generation index. United Therapeutics Corporation (UTHR) has a Free Cash Flow Generation Index of 0.66x as of June 2026. Free cash flow of $205.60 Million represents 1% of operating cash flow ($313.60 Million). Check United Therapeutics Corporation liquidity resilience to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of United Therapeutics Corporation (2004–2025)
Free cash flow generation index of United Therapeutics Corporation from 2004 to 2025. Historical FCF Generation Index trend for United Therapeutics Corporation across 20 annual periods. Explore UTHR capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
United Therapeutics Corporation Free Cash Flow Generation Index by Year (2004–2025)
United Therapeutics Corporation free cash flow generation index by year from 2004 to 2025. Year-by-year Free Cash Flow Generation Index for United Therapeutics Corporation. For the full cash flow conversion analysis, see United Therapeutics Corporation operating cash flow efficiency.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.67x | $1.04 Billion | $1.56 Billion | $520.50 Million | ▼ -18.1% |
| 2024 | 0.81x | $1.08 Billion | $1.33 Billion | $246.50 Million | ▲ +6.5% |
| 2023 | 0.76x | $747.60 Million | $978.00 Million | $230.40 Million | ▼ -7.6% |
| 2022 | 0.83x | $663.70 Million | $802.50 Million | $138.80 Million | ▲ +3.6% |
| 2021 | 0.80x | $477.40 Million | $598.20 Million | $120.80 Million | ▼ -13.4% |
| 2020 | 0.92x | $696.40 Million | $755.70 Million | $59.30 Million | ▲ +20.8% |
| 2018 | 0.76x | $594.00 Million | $778.40 Million | $184.40 Million | ▼ -6.7% |
| 2017 | 0.82x | $387.90 Million | $474.20 Million | $86.30 Million | ▼ -12.3% |
| 2016 | 0.93x | $600.40 Million | $643.60 Million | $43.20 Million | ▲ +7.2% |
| 2015 | 0.87x | $333.01 Million | $382.80 Million | $49.79 Million | ▲ +0.4% |
| 2014 | 0.87x | $307.86 Million | $355.30 Million | $47.44 Million | ▼ -6.3% |
| 2013 | 0.92x | $393.36 Million | $425.27 Million | $31.91 Million | ▲ +41.4% |
| 2012 | 0.65x | $211.72 Million | $323.63 Million | $111.91 Million | ▼ -23.6% |
| 2011 | 0.86x | $214.22 Million | $250.19 Million | $35.98 Million | ▼ -6.1% |
| 2010 | 0.91x | $192.89 Million | $211.53 Million | $18.64 Million | ▲ +3988.8% |
| 2009 | 0.02x | $2.22 Million | $99.72 Million | $95.40 Million | ▼ -89.5% |
| 2007 | 0.21x | $10.43 Million | $48.95 Million | $38.66 Million | ▼ -70.9% |
| 2006 | 0.73x | $36.15 Million | $49.39 Million | $15.63 Million | ▼ -15.9% |
| 2005 | 0.87x | $37.58 Million | $43.17 Million | $6.12 Million | ▲ +16.3% |
| 2004 | 0.75x | $15.56 Million | $20.78 Million | $5.22 Million | — |